Updated Dosing Recommendations Trumenba, MenB Vaccine

on May 24, 2017 in news



The Morbidity and Mortality Weekly report dated May 9th 2017 includes the updated Trumenba dosing recommendations of the Advisory Committee on Immunization Practices.  The ACIP recommends the 2-dose schedule of Trumenba when given to healthy adolescents and young adults, aged 16 through 23 years, who are not at increased risk for meningococcal disease, as a category B recommendation.